Relative Vaccine Effectiveness of the Third Dose of CoronaVac or BNT162b2 Following a Two-Dose CoronaVac Regimen: A Prospective Observational Cohort Study from an Adult Vaccine Center in Turkey

Coronavirus disease 2019 (COVID-19) continues to pose a threat to public health with the potential for the emergence of new variants. Vaccines are the milestones to control and slow down the damage of the pandemic. As of January 2021, a two-dose regimen with CoronaVac was authorized in Turkey. Due t...

Descripción completa

Detalles Bibliográficos
Autores principales: Sonmezer, Meliha Cagla, Dizman, Gulcin Telli, Erul, Enes, Sahin, Taha Koray, Saricaoglu, Tuğba, Alp, Alparslan, Tanriover, Mine Durusu, Uzun, Omrum, Unal, Serhat, Akova, Murat
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9322864/
https://www.ncbi.nlm.nih.gov/pubmed/35891304
http://dx.doi.org/10.3390/vaccines10071140

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9322864/
https://www.ncbi.nlm.nih.gov/pubmed/35891304
http://dx.doi.org/10.3390/vaccines10071140

Ejemplares similares